AIM
BEAT

Acrospire Investment Management’s BioTelemetry, Inc. BEAT Stock Holding History

Acrospire Investment Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,411
Closed -$47K – 2065
2017
Q2 		$47K Sell
1,411
-1,075
-43% -$32.1K 0.04% 925
2017
Q1 		$72K Sell
2,486
-4,799
-66% -$119K 0.06% 604
2016
Q4 		$163K Buy
7,285
+173
+2% +$3.38K 0.07% 532
2016
Q3 		$132K Sell
7,112
-1,102
-13% -$20.8K 0.09% 349
2016
Q2 		$134K Buy
8,214
+4,900
+148% +$72.1K 0.1% 244
2016
Q1 		$39K Buy
+3,314
New +$37K 0.03% 1161

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acrospire Investment Management's BEAT Position: Q3 2017 in Review

Acrospire Investment Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2017, closing a stake of 1,411 shares — an estimated $47K sold.

Acrospire Investment Management first reported a position in BEAT in Q1 2016 and held it in 6 quarters. The position peaked at $163K in Q4 2016. 211 funds tracked by Wall St. Rank hold BEAT as of Q3 2017.

  • Acrospire Investment Management reported no remaining BioTelemetry, Inc. position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,411 BioTelemetry, Inc. shares in Q3 2017, an estimated $47K.
  • Acrospire Investment Management first reported a position in BioTelemetry, Inc. in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's BioTelemetry, Inc. position peaked at $163K in Q4 2016.
  • 211 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.